The temperature controlled pharmaceutical containers market has seen considerable growth due to a variety of factors.
• The market for temperature regulated pharmaceutical containers has experienced speedy expansion in the past few years. It is anticipated to rise from $6.07 billion in 2024 to $6.72 billion in 2025, with a compound annual growth rate (CAGR) of 10.6%. Factors such as the escalation in pharmaceutical transport, adherence to regulatory standards, global integration of pharmaceutical supply chains, growing intricacy of pharmaceutical products and a strong emphasis on patient safety have contributed to the growth experienced in the historic period.
The Temperature Controlled Pharmaceutical Containers market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market for temperature-controlled pharmaceutical containers is projected to have rapid expansion. The market is forecasted to reach $10.7 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.3%.
This anticipated growth between now and the forecast period is due to factors such as the expansion of the biopharmaceutical market, emphasis on last-mile delivery, stricter regulations, the rise in personalized medicine, global health crises and the need for vaccinations. The key trends in the forecast period include the development of cold chain technologies, the globalization of pharmaceutical supply chains, the adoption of advanced insulation and thermal barrier materials, and an increase in the outsourcing of cold chain logistics.
The surge in vaccine sales is propelling the need for temperature-controlled pharmaceutical containers in the market. Vaccines, which are a type of medicine meant to amplify the body's immune response against diseases, help fight against infections that the body has not previously encountered and are meant for prevention rather than treatment. For the sake of safety, vaccines and other temperature-sensitive items require storage and transportation in containers that can control temperature. For example, between January 1 and March 24, 2024, NHS England, a government department based in England, saw a nearly 23% increase in MMR vaccinations, totaling 360,964 from the previous 293,847 in 2023. This figure comprises 187,737 initial doses and 172,635 booster doses. As a result, the rise in vaccine sales is likely to fuel the expansion of the market for temperature-controlled pharmaceutical containers.
The temperature controlled pharmaceutical containers market covered in this report is segmented –
1) By Control: Active, Passive
2) By Form: Chest Style, Upright Style
3) By Content Type: Vaccines Or Drugs, Samples, Reagents, Genetic Materials
4) By End User: Pharmaceutical, Clinical Trial
Subsegments:
1) By Active: Refrigerated Active Containers, Heated Active Containers, Temperature Monitoring Systems
2) By Passive: Insulated Containers, Gel Packs And Phase Change Materials, Refrigerants And Dry Ice
The emergence and creation of innovative packaging solutions is a growing trend in the temperature-controlled pharmaceutical containers market. Key players in this industry are honing their focus on innovation and deploying unique packaging solutions to maintain their market presence. To illustrate, in March 2022, Tower Cold Chain, a company based in the UK, specialized in the manufacturing of packaging and containers, introduced the KTEvolution container, specifically designed for the shipment of pharmaceutical, life sciences, and biomedical products under regulated temperature conditions. The core of KTEvolution container technology involves compact, vacuum-insulated panels combined with phase-change technology, allowing for extended thermal protection that doesn't need human maintenance. The essence of its innovation lies in its lightweight webbing system, a few fasteners and fittings that are wrapped around the body of the container.
Major companies operating in the temperature controlled pharmaceutical containers market include:
• American Aerogel Corporation
• AmerisourceBergen Corporation
• Cold Chain Technologies Inc.
• Envirotainer Ltd.
• FedEx Corporation
• Inmark LLC
• Intelsius Ltd.
• Snyder Industries LLC
• Sofrigam SAS
• Sonoco Company
• Tempack Packaging Solutions SL
• United Parcel Service of America Inc.
• Va-Q-tec AG
• Pelican BioThermal LLC
• Softbox Systems Ltd.
• Cryopak Industries Inc.
• DHL International GmbH
• Kuehne + Nagel International AG
• World Courier Inc.
• Kalibox SA
• Kodiak Technologies
• Mesa Laboratories Inc.
• Sorba-Freeze Ltd.
• Termo-Kont MK LLC
• Thermal Shipping Solutions
• Thomas EMS
• The Wool Packaging Company
• Zarges GmbH
• AeroSafe Global Inc.
• B Medical Systems SàRL
• Insulated Packaging Corp.
North America was the largest region in the temperature controlled pharmaceutical containers market share in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the temperature controlled pharmaceutical containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.